[(CD30+) anaplastic large-cell lymphoma (Ki-1 anaplastic lymphoma)]. 1996

E Liozon, and M Touati, and C Lavignac
Service de Médecine Interne A, CHRU Dupuytren, Limoges.

UI MeSH Term Description Entries
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D017728 Lymphoma, Large-Cell, Anaplastic A systemic, large-cell, non-Hodgkin, malignant lymphoma characterized by cells with pleomorphic appearance and expressing the CD30 ANTIGEN. These so-called "hallmark" cells have lobulated and indented nuclei. This lymphoma is often mistaken for metastatic carcinoma and MALIGNANT HISTIOCYTOSIS. Anaplastic Large-Cell Lymphoma,CD30-Positive Anaplastic Large-Cell Lymphoma,Lymphoma, Large-Cell, Ki-1,CD30+ Anaplastic Large-Cell Lymphoma,Ki-1 Lymphoma,Systemic Anaplastic Large-Cell Lymphoma,Anaplastic Large Cell Lymphoma,Anaplastic Large-Cell Lymphomas,CD30 Positive Anaplastic Large Cell Lymphoma,CD30+ Anaplastic Large Cell Lymphoma,Ki 1 Lymphoma,Ki-1 Lymphomas,Large-Cell Lymphoma, Anaplastic,Large-Cell Lymphomas, Anaplastic,Lymphoma, Anaplastic Large-Cell,Lymphoma, Ki-1,Lymphomas, Anaplastic Large-Cell,Lymphomas, Ki-1,Systemic Anaplastic Large Cell Lymphoma

Related Publications

E Liozon, and M Touati, and C Lavignac
November 1995, Annals of oncology : official journal of the European Society for Medical Oncology,
E Liozon, and M Touati, and C Lavignac
January 1993, Medical and pediatric oncology,
E Liozon, and M Touati, and C Lavignac
October 2010, Cirugia espanola,
E Liozon, and M Touati, and C Lavignac
January 1989, Annales de dermatologie et de venereologie,
E Liozon, and M Touati, and C Lavignac
August 2004, Archives of pathology & laboratory medicine,
E Liozon, and M Touati, and C Lavignac
November 1992, Cancer,
E Liozon, and M Touati, and C Lavignac
December 1994, Ceskoslovenska patologie,
E Liozon, and M Touati, and C Lavignac
May 1999, Journal of the American Academy of Dermatology,
E Liozon, and M Touati, and C Lavignac
February 1998, Digestive diseases and sciences,
E Liozon, and M Touati, and C Lavignac
November 1995, International journal of dermatology,
Copied contents to your clipboard!